Nov 3 (Reuters) - TScan Therapeutics Inc TCRX.O:
TSCAN THERAPEUTICS INC - EXPECTS $2.3 MILLION ONE-TIME CHARGE FOR SEVERANCE DURING 3 MONTHS ENDED DEC 31 - SEC FILING
Source text: [ID:n0001193125-25-261612]
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))